These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19478869)

  • 1. Viral sequestration of antigen subverts cross presentation to CD8(+) T cells.
    Tewalt EF; Grant JM; Granger EL; Palmer DC; Heuss ND; Gregerson DS; Restifo NP; Norbury CC
    PLoS Pathog; 2009 May; 5(5):e1000457. PubMed ID: 19478869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-MHC-I from Endogenous Antigen Outnumber Those from Exogenous Antigen, Irrespective of APC Phenotype or Activation.
    Sei JJ; Haskett S; Kaminsky LW; Lin E; Truckenmiller ME; Bellone CJ; Buller RM; Norbury CC
    PLoS Pathog; 2015 Jun; 11(6):e1004941. PubMed ID: 26107264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged antigen presentation following an acute virus infection requires direct and then cross-presentation.
    Heipertz EL; Davies ML; Lin E; Norbury CC
    J Immunol; 2014 Oct; 193(8):4169-77. PubMed ID: 25225666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells.
    Smed-Sörensen A; Chalouni C; Chatterjee B; Cohn L; Blattmann P; Nakamura N; Delamarre L; Mellman I
    PLoS Pathog; 2012; 8(3):e1002572. PubMed ID: 22412374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redundancy renders the glycoprotein 96 receptor scavenger receptor A dispensable for cross priming in vivo.
    Tewalt EF; Maynard JC; Walters JJ; Schell AM; Berwin BL; Nicchitta CV; Norbury CC
    Immunology; 2008 Dec; 125(4):480-91. PubMed ID: 18489571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of MHC Class I Processing Pathways That Generate a Response to Vaccinia Virus Late Proteins.
    Niu TK; Princiotta MF; Sei JJ; Norbury CC
    Immunohorizons; 2019 Dec; 3(12):559-572. PubMed ID: 31791977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response.
    Xu RH; Remakus S; Ma X; Roscoe F; Sigal LJ
    PLoS Pathog; 2010 Feb; 6(2):e1000768. PubMed ID: 20169189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.
    Busche A; Jirmo AC; Welten SP; Zischke J; Noack J; Constabel H; Gatzke AK; Keyser KA; Arens R; Behrens GM; Messerle M
    J Immunol; 2013 Mar; 190(6):2767-77. PubMed ID: 23390296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell migration limits the duration of CD8+ T-cell priming to peripheral viral antigen.
    Schell AM; Granger EL; Koczot F; Fischer MA; Norbury CC
    J Virol; 2010 Apr; 84(7):3586-94. PubMed ID: 20089641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8
    Murata Y; Kawashima K; Sheikh K; Tanaka Y; Isogawa M
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30089700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-priming utilizes antigen not available to the direct presentation pathway.
    Donohue KB; Grant JM; Tewalt EF; Palmer DC; Theoret MR; Restifo NP; Norbury CC
    Immunology; 2006 Sep; 119(1):63-73. PubMed ID: 16764686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct antigen presentation is the canonical pathway of cytomegalovirus CD8 T-cell priming regulated by balanced immune evasion ensuring a strong antiviral response.
    Büttner JK; Becker S; Fink A; Brinkmann MM; Holtappels R; Reddehase MJ; Lemmermann NA
    Front Immunol; 2023; 14():1272166. PubMed ID: 38149242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo.
    Schliehe C; Bitzer A; van den Broek M; Groettrup M
    J Virol; 2012 Sep; 86(18):9782-93. PubMed ID: 22761378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective Priming of Herpes Simplex Virus-Specific CD8
    Whitney PG; Makhlouf C; MacLeod B; Ma JZ; Gressier E; Greyer M; Hochheiser K; Bachem A; Zaid A; Voehringer D; Heath WR; Wagle MV; Parish I; Russell TA; Smith SA; Tscharke DC; Gebhardt T; Bedoui S
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cross-priming pathway: a portrait of an intricate immune system.
    Basta S; Alatery A
    Scand J Immunol; 2007 Apr; 65(4):311-9. PubMed ID: 17386021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II.
    Rehm KE; Connor RF; Jones GJ; Yimbu K; Mannie MD; Roper RL
    Immunology; 2009 Nov; 128(3):381-92. PubMed ID: 20067538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
    Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice.
    Iborra S; Izquierdo HM; Martínez-López M; Blanco-Menéndez N; Reis e Sousa C; Sancho D
    J Clin Invest; 2012 May; 122(5):1628-43. PubMed ID: 22505455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation.
    Longo Y; Mascaraque SM; Andreacchio G; Werner J; Katahira I; De Marchi E; Pegoraro A; Lebbink RJ; Köhrer K; Petzsch P; Tao R; Di Virgilio F; Adinolfi E; Drexler I
    Front Immunol; 2024; 15():1360140. PubMed ID: 38711513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4⁺ T cells but are incapable of cross-presentation.
    van der Vlist M; de Witte L; de Vries RD; Litjens M; de Jong MA; Fluitsma D; de Swart RL; Geijtenbeek TB
    Eur J Immunol; 2011 Sep; 41(9):2619-31. PubMed ID: 21739428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.